The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Initially a blockbuster drug, yielding billions in revenue , its patent expiration created a wave of knock-off https://myfirstbookmark.com/story21430999/sildenafil-and-big-pharma-a-risky-investment